Experimental Drug Reverses MS Damage in Mouse Model
An experimental therapeutic has successfully reversed myelin damage and restored neurological function in a preclinical mouse model of multiple sclerosis. Published in recent pharmacological studies, the approach targets distinct cellular … Read More